Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1986-02-24
1989-08-29
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514844, 514859, 514861, 514864, A61K 31715
Patent
active
048617610
ABSTRACT:
The present invention is directed to a substantially pure therapeutically active aloe isolate having a molecular weight of about 70,000 and a dialysis method for making said aloe isolate.
REFERENCES:
patent: 3103466 (1963-09-01), Farkas
patent: 3362951 (1968-01-01), Farkas et al.
patent: 3892853 (1975-07-01), Cobble
patent: 4225486 (1980-09-01), Suzuki
patent: 4488482 (1984-12-01), Cottrell
patent: 4598069 (1986-07-01), Hikino et al.
Mandal et al., Carbohydrate Res. 87:249-256, 1980.
Mandal et al., Ind. J. Chem. 22B:898-893, 1983.
Chem. Abst. 86:86163r, 1977.
Chem. Abst. 94:136159g, 1981.
Madis Valdemar H.
Madis Voldemar
Omar Mostafa M.
Dr. Madis Laboratories, Inc.
Rollins John W.
LandOfFree
Aloeferon isolation, manufacturing and its applications does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aloeferon isolation, manufacturing and its applications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aloeferon isolation, manufacturing and its applications will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2238333